COGT position history
The shares of Cogent Biosciences (COGT) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 600,000 shares, $5M, 0.03% of portfolio
- 2021 Q4: 600,000 shares, $5.1M, 0.03% of portfolio
- 2022 Q1: 850,000 shares, $6.4M, 0.03% of portfolio, Add +41.7%
- 2022 Q2: 1,000,000 shares, $9M, 0.06% of portfolio, Add +17.6%
- 2022 Q3: 245,139 shares, $3.7M, 0.02% of portfolio, Reduce −75.5%
- 2022 Q4: 85,139 shares, $984K, <0.01% of portfolio, Reduce −65.3%
- 2023 Q1: 983,452 shares, $11M, 0.06% of portfolio, Add +1055.1%
- 2023 Q2: 983,452 shares, $12M, 0.07% of portfolio
- 2023 Q3: 17,000 shares, $166K, <0.01% of portfolio, Reduce −98.3%
- 2023 Q4: 17,000 shares, $100K, <0.01% of portfolio
- 2024 Q1: 924,000 shares, $6.2M, 0.03% of portfolio, Add +5335.3%
- 2024 Q2: 425,161 shares, $3.6M, 0.02% of portfolio, Reduce −54.0%
- 2024 Q3: 17,000 shares, $184K, <0.01% of portfolio, Reduce −96.0%
- 2024 Q4: 17,000 shares, $133K, <0.01% of portfolio
- 2025 Q1: 17,000 shares, $102K, <0.01% of portfolio
- 2025 Q2: 17,000 shares, $122K, <0.01% of portfolio
- 2025 Q3: 34,000 shares, $488K, <0.01% of portfolio, Add +100.0%
- 2025 Q4: 17,000 shares, $604K, <0.01% of portfolio, Reduce −50.0%
- 2026 Q1: 17,000 shares, $654K, <0.01% of portfolio
- 2026 Q2: 17,000 shares, $658K, <0.01% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|